
|Articles|May 24, 2017
- May 2017 Skin & Eye Health
- Volume 83
- Issue 5
Can You Read These Rxs? (May 2017)
Can you figure out what these prescriptions say?
Advertisement
Send in your eye-straining, baffling prescriptions—now via e-mail and fax as well as regular mail! Submissions must include a clean photocopy or scanned image of the Rx; your institution’s name and location; your name and title; the correct name of the drug(s), strength, and dosing requirements; and your phone number. You can e-mail scanned Rxs to rmarotta@pharmacytimes.com; fax them to 609-257-0701; or mail them to Can You Read These Rxs?, Pharmacy Times, 2 Clarke Drive, Suite 100, Cranbury, NJ 08512.
Articles in this issue
over 9 years ago
Pet Peeves (May 2017)over 9 years ago
Case Studies (May 2017)over 9 years ago
Generic Product News (May 2017)over 9 years ago
FDA Report Recaps Progress, Goals in Generic Drug Approvalsover 9 years ago
Children Face Greatest Risk of Sport-Related Eye Injuriesover 9 years ago
LASIK Poses Lower Risk of Infection Than Contactsover 9 years ago
Sodium Intake Remains High Among Hypertension PatientsAdvertisement
Related to this article

How should a factor XIa inhibitor be incorporated into secondary stroke prevention?

OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.

Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.

The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.

Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.

Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
2
Glucose Monitoring: Timing Makes Every Reading Count
3
Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines
4
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
5


